NeuroPace (NPCE) Stock: Insider Trades, Congress & Funds

Smart money at a glance

Filings to Nov 9, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, latest quarter: No large changes
Federal contractsUSAspending.gov, 12 months: 6 awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about NPCE filings

Are insiders buying or selling Neuropace Inc (NPCE) stock?

Neither. Neuropace Inc (NPCE) insiders filed no open-market purchases or sales in the 90 days to Nov 9, 2026, according to SEC Form 4 filings.

Which members of Congress have traded NPCE recently?

None. No member of Congress disclosed a NPCE trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this NPCE smart-money data?

This summary uses filings available on Nov 9, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

No recent filings found.

19 funds hold a position.

Questions about NPCE filings

Are insiders buying or selling Neuropace Inc (NPCE) stock?

Neither. Neuropace Inc (NPCE) insiders filed no open-market purchases or sales in the 90 days to Nov 9, 2026, according to SEC Form 4 filings.

Which members of Congress have traded NPCE recently?

None. No member of Congress disclosed a NPCE trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this NPCE smart-money data?

Checking federal contract awards

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 11, 2026

Earnings came in 5.6% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 11, 2026

Period ending

Jun 30, 2026

Earnings per share

-$0.18+5.58% beat

-$0.19 expected

Revenue

$22.8M

SEC filing

EPS: Yahoo Finance

Next report

Estimated report: Nov 12, 2026, in 3 days

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jun 30, 2026Reported Aug 11, 2026	-$0.18est. -$0.19	+5.58%beat	$22.8MSEC filing	+17.1%from $19.5M
Mar 31, 2026Reported May 12, 2026	-$0.20est. -$0.23	+13.59%beat	$22.1MSEC filing	-2.0%from $22.5M
Dec 31, 2025Reported Mar 3, 2026	-$0.08est. -$0.15	+48.11%beat	$26.6MYahoo Finance	No year-ago quarter
Sep 30, 2025Reported Nov 4, 2025	-$0.11est. -$0.19	+43.55%beat	$27.4MSEC filing	+29.9%from $21.1M
Jun 30, 2025Reported Aug 12, 2025	-$0.26est. -$0.22	-18.18%miss	$19.5MSEC filing	+1.3%from $19.3M
Mar 31, 2025Reported May 13, 2025	-$0.21est. -$0.24	+12.50%beat	$22.5MSEC filing	+24.3%from $18.1M
Dec 31, 2024Reported Mar 4, 2025	-$0.18est. -$0.22	+19.39%beat	$79.9M · FYSEC filing	No year-ago quarter
Sep 30, 2024Reported Nov 12, 2024	-$0.19est. -$0.27	+29.63%beat	$21.1MSEC filing	+28.2%from $16.4M

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $12.69
High: $13.01
Low: $12.14
Prev close: $12.69
52-wk high: $19.60
52-wk low: $12.00
Mkt cap: $429.1M
ROE: -103.3%
Fwd P/E: 140.8x
Beta: 1.93
P/S: 4.0x
P/B: 36.7x
Profit margin: -17.9%
Op margin: -22.5%

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -17.9%
Forward P/E: 140.85
Market cap: $429M

Valuation

P/S4.01
P/B36.66

Quality

Operating margin-22.5%
ROE-103.3%
ROA-7.5%

Growth

Beta1.93

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

15 / 100

RSI 14

47balanced

20D volatility

55%annualized

52-week range

$12.50

$12.00$19.60

20D support

$12.00recent floor

20D resistance

$13.94recent ceiling

Returns

5D +1.6%20D -1.3%60D -13.9%

Price vs moving averages

SMA20 -2.4%SMA50 -7.6%SMA200 -16.0%

Volume pace

0.81xvs prior 20D

Smart money at a glance

Filings to Nov 9, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, latest quarter: No large changes
Federal contractsUSAspending.gov, 12 months: 6 awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about NPCE filings

Are insiders buying or selling Neuropace Inc (NPCE) stock?

Neither. Neuropace Inc (NPCE) insiders filed no open-market purchases or sales in the 90 days to Nov 9, 2026, according to SEC Form 4 filings.

Which members of Congress have traded NPCE recently?

None. No member of Congress disclosed a NPCE trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this NPCE smart-money data?

No recent filings found.

19 funds hold a position.

Questions about NPCE filings

Are insiders buying or selling Neuropace Inc (NPCE) stock?

Neither. Neuropace Inc (NPCE) insiders filed no open-market purchases or sales in the 90 days to Nov 9, 2026, according to SEC Form 4 filings.

Which members of Congress have traded NPCE recently?

None. No member of Congress disclosed a NPCE trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this NPCE smart-money data?

Checking federal contract awards

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 11, 2026

Earnings came in 5.6% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 11, 2026

Period ending

Jun 30, 2026

Earnings per share

-$0.18+5.58% beat

-$0.19 expected

Revenue

$22.8M

SEC filing

EPS: Yahoo Finance

Next report

Estimated report: Nov 12, 2026, in 3 days

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jun 30, 2026Reported Aug 11, 2026	-$0.18est. -$0.19	+5.58%beat	$22.8MSEC filing	+17.1%from $19.5M
Mar 31, 2026Reported May 12, 2026	-$0.20est. -$0.23	+13.59%beat	$22.1MSEC filing	-2.0%from $22.5M
Dec 31, 2025Reported Mar 3, 2026	-$0.08est. -$0.15	+48.11%beat	$26.6MYahoo Finance	No year-ago quarter
Sep 30, 2025Reported Nov 4, 2025	-$0.11est. -$0.19	+43.55%beat	$27.4MSEC filing	+29.9%from $21.1M
Jun 30, 2025Reported Aug 12, 2025	-$0.26est. -$0.22	-18.18%miss	$19.5MSEC filing	+1.3%from $19.3M
Mar 31, 2025Reported May 13, 2025	-$0.21est. -$0.24	+12.50%beat	$22.5MSEC filing	+24.3%from $18.1M
Dec 31, 2024Reported Mar 4, 2025	-$0.18est. -$0.22	+19.39%beat	$79.9M · FYSEC filing	No year-ago quarter
Sep 30, 2024Reported Nov 12, 2024	-$0.19est. -$0.27	+29.63%beat	$21.1MSEC filing	+28.2%from $16.4M

Open: $12.69
High: $13.01
Low: $12.14
Prev close: $12.69
52-wk high: $19.60
52-wk low: $12.00
Mkt cap: $429.1M
ROE: -103.3%
Fwd P/E: 140.8x
Beta: 1.93
P/S: 4.0x
P/B: 36.7x
Profit margin: -17.9%
Op margin: -22.5%

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -17.9%
Forward P/E: 140.85
Market cap: $429M

Valuation

P/S4.01
P/B36.66

Quality

Operating margin-22.5%
ROE-103.3%
ROA-7.5%

Growth

Beta1.93

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

15 / 100

RSI 14

47balanced

20D volatility

55%annualized

52-week range

$12.50

$12.00$19.60

20D support

$12.00recent floor

20D resistance

$13.94recent ceiling

Returns

5D +1.6%20D -1.3%60D -13.9%

Price vs moving averages

SMA20 -2.4%SMA50 -7.6%SMA200 -16.0%

Volume pace

0.81xvs prior 20D

Neuropace Inc

Smart money at a glance

What do analysts expect?

Questions about NPCE filings

Questions about NPCE filings

How top traders are positioned

Unlock everything for $29/month

Earnings came in 5.6% above what analysts expected.

Estimated report: Nov 12, 2026, in 3 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Neuropace Inc

Smart money at a glance

What do analysts expect?

Questions about NPCE filings

Questions about NPCE filings

How top traders are positioned

Unlock everything for $29/month

Earnings came in 5.6% above what analysts expected.

Estimated report: Nov 12, 2026, in 3 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Neuropace Inc

Overview

Questions about NPCE filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Neuropace Inc

Overview

Questions about NPCE filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.